1. Home
  2. BIOT vs APRE Comparison

BIOT vs APRE Comparison

Compare BIOT & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Instinct Bio Technical Company Holdings Inc. Ordinary Shares

BIOT

Instinct Bio Technical Company Holdings Inc. Ordinary Shares

N/A

Current Price

$0.18

Market Cap

6.6M

Sector

N/A

ML Signal

N/A

Logo Aprea Therapeutics Inc.

APRE

Aprea Therapeutics Inc.

N/A

Current Price

$0.49

Market Cap

5.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BIOT
APRE
Founded
2017
2006
Country
Japan
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
5.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BIOT
APRE
Price
$0.18
$0.49
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $3.30
AVG Volume (30 Days)
★ 429.1K
177.9K
Earning Date
N/A
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 21.22
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.41
52 Week High
$50.00
$1.49

Technical Indicators

Market Signals
Indicator
BIOT
APRE
Relative Strength Index (RSI) 11.31 39.72
Support Level $0.17 $0.41
Resistance Level $0.50 $0.81
Average True Range (ATR) 0.03 0.06
MACD 0.03 -0.00
Stochastic Oscillator 6.65 37.42

Price Performance

Historical Comparison
BIOT
APRE

About BIOT Instinct Bio Technical Company Holdings Inc. Ordinary Shares

Instinct Bio Technical Company Holdings Inc is a Cayman Islands-based vertically integrated group engaged in the research and development, manufacturing, branding, and distribution of stem cells, regenerative medicine, wellness, and beauty as its core areas. Its product portfolio includes stem cell-derived serums and skincare formulations for aesthetic and dermatological applications. The company also develops regenerative products for skin healing, hydration, and elasticity.

About APRE Aprea Therapeutics Inc.

Aprea Therapeutics Inc is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers. It develops small molecule inhibitors designed to exploit genetic mutations in cancer to widen the therapeutic window and is intended to make treatments more effective at destroying cancer cells while sparing healthy tissue. The company's pipeline of clinical and preclinical programs includes APR-1051, a WEE1 inhibitor; ATRN-119 (Mosipasertib), an oral small molecule inhibitor of ataxia telangiectasia and Rad3-related, or ATR; and an early-stage program, APR-1602. These candidates are being developed for broad applications in cancer treatment.

Share on Social Networks: